DNMT 활성 부위의 시스테인 잔류물과 공유 결합을 형성하는 것으로 나타난 메커니즘 기반 DNMT 억제제입니다.
5-Fluoro-2′-deoxycytidine (CAS 10356-76-0) 참고자료
1. Zheng, Y. G., et al., Chemical Regulation of Epigenetic Modifications: Opportunities for New Cancer Therapy. Med. Res. Rev. 28, 645-687, (2008) Warncke S, et al., Phosphorothioation of oligonucleotides strongly influences the inhibition of bacterial (M.HhaI) and human (Dnmt1) DNA methyltransferases. ChemBioChem. 10, 728-734, (2009) 2. Beumer, J.H., et al., Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine in mice. Clin. Cancer Res. 12, 7483-7491, (2006)